Nishat Tasnim

Ms. Nishat Tasnim

UBC School of Engineering
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
XLXia Li
Xia Li
ACAlexander L. Corbett
Alexander L. Corbett
ETErfan Taatizadeh
Erfan Taatizadeh
Nishat TasnimNishat Tasnim
Nishat Tasnim
JLJonathan P. Little
Jonathan P. Little
ILIsaac Li
Isaac Li
Exosomes are small (∼30–140 nm) lipid bilayer-enclosed particles of endosomal origin. They are a subset of extracellular vesicles (EVs) that are secreted by most cell types. There has been growing interest in exosome research in the last decade due to their emerging role as intercellular messengers and their potential in disease diagnosis. Indeed, exosomes contain proteins, lipids, and RNAs that are specific to their cell origin and could deliver cargo to both nearby and distant cells. As a result, investigation of exosome cargo contents could offer opportunities for disease detection and treatment. Moreover, exosomes have been explored as natural drug delivery vehicles since they can travel safely in extracellular fluids and deliver cargo to destined cells with high specificity and efficiency. Despite significant efforts made in this relatively new field of research, progress has been held back by challenges such as inefficient separation methods, difficulties in characterization, and lack of specific biomarkers. In this review, we summarize the current knowledge in exosome biogenesis, their roles in disease progression, and therapeutic applications and opportunities in bioengineering. Furthermore, we highlight the established and emerging technological developments in exosome isolation and characterization. We aim to consider critical challenges in exosome research and provide directions for future studies.

7 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMonika A Gorzelak
Monika A Gorzelak
SGSandeep K Gill
Sandeep K Gill
Nishat TasnimNishat Tasnim
Nishat Tasnim
ZAZahra Ahmadi-Vand
Zahra Ahmadi-Vand
MJMichael Jay
Michael Jay
Deanna GibsonDeanna Gibson
Deanna Gibson
Gut microbiome community analysis is used to understand many diseases like inflammatory bowel disease, obesity, and diabetes. Sampling methods are an important consideration for human microbiome research, yet are not emphasized in many studies. In this study, we demonstrate that the preparation, handling, and storage of human faeces are critical processes that alter the outcomes of downstream DNA-based bacterial community analyses via qPCR. We found that stool subsampling resulted in large variability of gut microbiome data due to different microenvironments harbouring various taxa within an individual stool. However, we reduced intra-sample variability by homogenizing the entire stool sample in liquid nitrogen and subsampling from the resulting crushed powder prior to DNA extraction. We experimentally determined that the bacterial taxa varied with room temperature storage beyond 15 minutes and beyond three days storage in a domestic frost-free freezer. While freeze thawing only had an effect on bacterial taxa abundance beyond four cycles, the use of samples stored in RNAlater should be avoided as overall DNA yields were reduced as well as the detection of bacterial taxa. Overall we provide solutions for processing and storing human stool samples that reduce variability of microbiome data. We recommend that stool is frozen within 15 minutes of being defecated, stored in a domestic frost-free freezer for less than three days, and homogenized prior to DNA extraction. Adoption of these simple protocols will have a significant and positive impact on future human microbiome research.

1 November 2021 in Food Hydrocolloids
Verified
Journal Article
Closed access
SRSeyedehhamideh Razavi
Seyedehhamideh Razavi
SJSajjad Janfaza
Sajjad Janfaza
Nishat TasnimNishat Tasnim
Nishat Tasnim
Deanna GibsonDeanna Gibson
Deanna Gibson
MHMina Hoorfar
Mina Hoorfar

6 October 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
Nishat TasnimNishat Tasnim
Nishat Tasnim
NANijiati Abulizi
Nijiati Abulizi
JPJason Pither
Jason Pither
MHMiranda Hart
Miranda Hart
Deanna GibsonDeanna Gibson
Deanna Gibson
Global comparisons reveal a decrease in gut microbiota diversity attributed to Western diets, lifestyle practices such as caesarian section, antibiotic use and formula-feeding of infants, and sanitation of the living environment. While gut microbial diversity is decreasing, the prevalence of chronic inflammatory diseases such as inflammatory bowel disease, Type 2 1 diabetes, obesity, allergies and asthma is on the rise in Westernized societies. Since the immune system development is influenced by microbial components, early microbial colonization may be a key factor in determining disease susceptibility patterns later in life. Evidence indicates that the gut microbiota is vertically transmitted from the mother and this affects offspring immunity. However, the role of the external environment in gut microbiome and immune development is poorly understood. Studies show that growing up in microbe-rich environments, such as traditional farms, can have protective health effects on children. These health-effects may be ablated due to changes in the human lifestyle, diet, living environment and environmental biodiversity as a result of urbanization. Importantly, if If early-life exposure to environmental microbes increases gut microbiota diversity by influencing patterns of gut microbial assembly, then soil biodiversity loss due to land-use changes such as urbanization could be a public health threat. Here, we summarize key questions in environmental health research and discuss some of the challenges that have hindered progress towards a better understanding of the role of the environment on gut microbiome development.

30 March 2021 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
SRSeyedehhamideh Razavi
Seyedehhamideh Razavi
SJSajjad Janfaza
Sajjad Janfaza
Nishat TasnimNishat Tasnim
Nishat Tasnim
DGDeanna L. Gibson
Deanna L. Gibson
Mina HoorfarMina Hoorfar
Mina Hoorfar
Nanomaterials have demonstrated significant promise as encapsulation materials to improve probiotic encapsulation. The integration of nanotechnology with microencapsulation techniques can improve the controlled delivery of viable probiotic bacteria to the gut.

25 November 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
Kaushiki DixitKaushiki Dixit
Kaushiki Dixit
Somayeh FardindoostSomayeh Fardindoost
Somayeh Fardindoost
ARAdithya Ravishankara
Adithya Ravishankara
Nishat TasnimNishat Tasnim
Nishat Tasnim
Mina HoorfarMina Hoorfar
Mina Hoorfar
With the global population prevalence of diabetes surpassing 463 million cases in 2019 and diabetes leading to millions of deaths each year, there is a critical need for feasible, rapid, and non-invasive methodologies for continuous blood glucose monitoring in contrast to the current procedures that are either invasive, complicated, or expensive. Breath analysis is a viable methodology for non-invasive diabetes management owing to its potential for multiple disease diagnoses, the nominal requirement of sample processing, and immense sample accessibility; however, the development of functional commercial sensors is challenging due to the low concentration of volatile organic compounds (VOCs) present in exhaled breath and the confounding factors influencing the exhaled breath profile. Given the complexity of the topic and the skyrocketing spread of diabetes, a multifarious review of exhaled breath analysis for diabetes monitoring is essential to track the technological progress in the field and comprehend the obstacles in developing a breath analysis-based diabetes management system. In this review, we consolidate the relevance of exhaled breath analysis through a critical assessment of current technologies and recent advancements in sensing methods to address the shortcomings associated with blood glucose monitoring. We provide a detailed assessment of the intricacies involved in the development of non-invasive diabetes monitoring devices. In addition, we spotlight the need to consider breath biomarker clusters as opposed to standalone biomarkers for the clinical applicability of exhaled breath monitoring. We present potential VOC clusters suitable for diabetes management and highlight the recent buildout of breath sensing methodologies, focusing on novel sensing materials and transduction mechanisms. Finally, we portray a multifaceted comparison of exhaled breath analysis for diabetes monitoring and highlight remaining challenges on the path to realizing breath analysis as a non-invasive healthcare approach.